BridgeBio Pharma, Inc. · NASDAQ:BBIO
Kumar Neil exercised options for 71,217 BridgeBio Pharma, Inc. shares (Form 4)
Traded Aug 16, 2026 · Filed Aug 18, 2026
On Aug 16, 2026, Kumar Neil (Director, Chief Executive Officer) exercised options for 71,217 BridgeBio Pharma, Inc. shares, leaving 278,307 shares. Filed Aug 18, 2026 (Form 4).
- Options exercised
- 71,217 shares
- Holding after
- 278,307 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 16, 2026 | Common Stock | Option exercise | 33,544 | 276,871 | Direct | |
| Aug 16, 2026 | Common Stock | Option exercise | 19,599 | 296,470 | Direct | |
| Aug 16, 2026 | Common Stock | Option exercise | 11,554 | 308,024 | Direct | |
| Aug 16, 2026 | Common Stock | Option exercise | 6,520 | 314,544 | Direct | |
| Aug 16, 2026 | Common Stock | Shares withheld for tax | 36,237 | US$79.86 | 278,307 | Direct |
Source
Related
- BridgeBio Pharma, Inc.
- Kumar Neil
- BridgeBio Pharma, Inc. shareholders
- Form 4 · Kumar Neil · Nov 20, 2026
- Form 4 · Kumar Neil · Nov 18, 2026
- Form 4 · Kumar Neil · Sep 21, 2026
- Form 4 · Kumar Neil · Aug 20, 2026
- Form 4 · Kumar Neil · Jun 8, 2026
- Form 4 · Apuli Maricel · Nov 18, 2026
- Form 4 · Trimarchi Thomas · Nov 18, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Nov 12, 2026
- Form 4 · Apuli Maricel · Nov 3, 2026
- Schedule 13G · BlackRock, Inc. · Oct 27, 2026